EAST
PROVIDENCE, R.I., July 9, 2024
/PRNewswire/ -- IlluminOss Medical, a medical device company
focused on minimally invasive orthopedic fracture repair, today
announced that it has appointed Craig
Decker as its new Chief Executive Officer. Previously, Mr.
Decker served as the Company's Vice President of Sales for the
Western U.S. Prior to joining IlluminOss, Mr. Decker had over 20
years of experience as Trauma sales leader at Stryker and led the
Commercial team for North America
at NuVasive Specialized Orthopedics.
"On behalf of the Board, we are delighted to have Craig lead
IlluminOss in its next phase of growth," said Mike Mogul,
Chairman of the Board of IlluminOss. "Craig is a highly
experienced and respected leader with a track record of significant
commercial success at larger medical device companies. He has deep
expertise and strong relationships within the trauma community. We
are confident that he will continue to steer IlluminOss toward even
greater success in the future."
"IlluminOss is a highly innovative technology that solves
difficult surgical challenges for the vulnerable orthogeriatric
patient population," said Craig
Decker, new CEO of IlluminOss. "The product is rapidly
becoming the standard of care in treating fragility fractures, and
I am honored to lead the Company at its next inflection point to
even higher growth."
About IlluminOss Medical
IlluminOss Medical, Inc. is a privately held, commercial-stage
medical device company offering a unique, minimally invasive
technology for fracture repair and stabilization. The Company
utilizes a light-curable monomer contained within an expandable
balloon to create a patient-conforming intramedullary implant for
bone stabilization. The revolutionary, minimally invasive
technology is particularly applicable for repair and treatment of
osteoporotic and compromised bone. The IlluminOss system is
CE-marked and FDA-cleared for a variety of anatomical sites, and
has over 10,000 implantations to date. IlluminOss is headquartered
in East Providence, RI.
For additional information, including complete list of
indications, contraindications, warnings, precautions and risks,
visit www.illuminoss.com.
For media inquiries, please contact: Tessa Cicitta, HealthpointCapital, 212-935-7780,
or tcicitta@healthpointcapital.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/illuminoss-medical-appoints-craig-decker-as-chief-executive-officer-302191289.html
SOURCE IlluminOss Medical